The experts in radioprotective and cytoprotective science.

The F3 Team combines:

  • More than four decades of diligent, dedicated research and development of Amifostine applications
  • An established history of execution and performance in companies from start-ups to large publicly traded institutions
  • A history of successful scientific product commercialization
  • Countless years of medical practice and specialization in radiation physics, radiation oncology, medical oncology, and cancer treatment
  • Deep experience in start-up and established pharmaceutical company management